Indication · Neurology & Neurosurgery
OCD, PTSD and other psychiatric conditions
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
63
Cleared or approved since 2000
PMA and De Novo
7
Higher-risk or first-of-kind devices
Breakthrough devices
5
Authorized through June 30, 2026
Recruiting device trials
288
1,787 device trials in all
Breakthrough-designated devices
- MeRT SystemWave Neuroscience · 2026
- AvertD and AvertD Buccal Sample Collection KitAutoGenomics, Inc. · 2026
- Magnus Neuromodulation System (MNS) with SAINT Technology, Model Number 1001KMagnus Medical, Inc. · 2022
2 more devices with a free account
Devices
63 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- AvertD and AvertD Buccal Sample Collection Kit
AutoGenomics, Inc. · PMA · Opioid Use Disorder Genetic Risk Variant Detection System And Collection Kit · newest 2026 · 5 decisions
- Modius Spero
Neurovalens Limited · De Novo · Transcranial Nerve Stimulation Device For The Treatment Of Post-Traumatic Stress Disorder Associated Symptoms · newest 2026
- NightWare Kit
Nightware, Inc. · De Novo · Digital Therapy Device To Reduce Sleep Disturbance For Psychiatric Conditions · newest 2020
57 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- RASSURE - Virtual Reality to Soothe, Secure, Simulate Uses, and Successfully Complete the ExaminationPivotal-lookingNot yet recruiting
Pôle Saint HélierAcademic, hospital or other
NCT07949097 · 100 participants (planned) · Start Dec 1, 2026 · Primary completion Mar 30, 2028
Device: Embrace Plus wristband; PREPASOINS_VR virtual reality headset and 1 more · For: Psychological Disability; Mental Disability
Sites: Rennes, France; Thorigné-Fouillard, France
Instituto de Investigación Sanitaria de la Fundación Jiménez DíazAcademic, hospital or other
NCT06968000 · 0 participants · Start Mar 1, 2025 · Primary completion Mar 1, 2026
Device: EOX Anion-Enriched Hospital Room · For: Inflammatory Response After Surgery; Postoperative Recovery
Sites: Madrid, Spain
Sunnybrook Health Sciences CentreAcademic, hospital or other
NCT07113665 · 10 participants (planned) · Start Sep 5, 2025 · Primary completion Aug 2028
Device: ExAblate Neuro 4000 · For: Anorexia Nervosa (DSM-IV Revised Criteria)
Sites: Toronto, Canada
1,784 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Transcranial Magnetic Stimulator (OBP)35
- Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder (QCI)9
- Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety (QJQ)9
- Computerized Behavioral Therapy Device For Substance Use Disorders (PWE)2
- Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder (QGH)1
- Clozapine Test System (QKT)1
- Digital Therapy Device To Reduce Sleep Disturbance For Psychiatric Conditions (QMZ)1
- Opioid Use Disorder Genetic Risk Variant Detection System And Collection Kit (QZH)1
- Computerized Behavioral Therapy Device For Anxiety Disorders (SCP)1
- Biofeedback For Adjunctive Treatment Of Symptoms Associated With Stress And Anxiety (SEN)1
- Transcranial Nerve Stimulation Device For The Treatment Of Post-Traumatic Stress Disorder Associated Symptoms (SHX)1
- Transcranial Magnetic Stimulation System For Post Traumatic Stress Disorder (Ptsd) (SIG)1
Research
- Device studies on obsessive-compulsive disorder across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.